Novo Nordisk Achieves Faster Trial Setup and Shorter Cycles with Veeva Clinical Data
Novo Nordisk implemented Veeva's clinical data solutions, integrating Veeva EDC and Veeva DQS, to accelerate clinical trial operations. The connection between EDC and DQS reduced study setup effort and enabled data availability from First Patient First Visit onward. Vice President Ibrahim Kamstrup-Akkaoui is quoted saying the EDC/DQS connection 'reduces study setup effort and ensures data availability from First Patient First Visit.' The result was shorter trial cycles and more standardized data management across the Veeva platform.
Veeva Systems is the dominant CRM and content platform in pharma commercial, regulatory, clinical and quality operations, now shipping AI agents directly inside those same production systems.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Veeva Systems on its own site — read the original case study on veeva.com ↗
Related use cases
- 01Transforming Content Operations for 2x Faster Time to Market
- 02Astellas: Breaking Access Barriers with Veeva Compliant Chat
- 03How Pacira Generated Deep Website Insights to Get Patients on Therapy Faster
- 04Reaching Underserved Communities with Smarter Targeting
- 05Building Agile Territory Strategies to Scale Pre-Commercial Field Teams
- 06How Alfasigma Unified Regulatory Data and Processes for Cross-Functional Alignment